Business · 26/07/2007
FDA Releases Draft Guidance for Cell Selection Devices for Autologous Peripheral Blood Stem Cells
The FDA has made available a draft document outlining the requirements for cell selection devices that minimize manipulation of autologous peripheral blood stem cells at the point of care, with the goal of supporting clinical indications and potential approval of these devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →